(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 12.63% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 5.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Cognex's revenue in 2024 is $837,547,000.On average, 4 Wall Street analysts forecast CGNX's revenue for 2024 to be $161,232,722,204, with the lowest CGNX revenue forecast at $154,641,987,126, and the highest CGNX revenue forecast at $167,068,268,888. On average, 3 Wall Street analysts forecast CGNX's revenue for 2025 to be $181,766,294,648, with the lowest CGNX revenue forecast at $179,357,243,670, and the highest CGNX revenue forecast at $183,821,436,883.
In 2026, CGNX is forecast to generate $204,587,401,392 in revenue, with the lowest revenue forecast at $204,587,401,392 and the highest revenue forecast at $204,587,401,392.